financetom
Business
financetom
/
Business
/
Clip Money Inc. Reports Issuance Of Options
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Clip Money Inc. Reports Issuance Of Options
Mar 11, 2024 2:02 PM

04:36 PM EDT, 03/11/2024 (MT Newswires) -- Clip Money Inc. ( CLPMF ) , a company that operates a multi-bank self-service deposit system for businesses, announced Monday the grant of an aggregate of 465,000 options to acquire common shares of the company to certain executives of the company to recognize their strong performance in 2023.

The following options have been granted: 275,000 Options to Joseph Arrage, 260,000 Options to Brian Bailey, 155,000 Options to Andrew Tussing, and 75,000 Options to Roger Dalal.

The Options have a three-year vesting period, an exercise price equal to $0.18, being the trading price of the Common Shares at the close of business on March 8, 2024, and will expire 10 years from the date of the grant.

The Options are governed by the terms of the company's omnibus equity incentive plan, under which an aggregate of 10.4 million Common Shares are issuable.

Price: 0.19, Change: +0.01, Percent Change: +5.5556

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioNTech says FDA lifts partial hold on its cancer drug trial
BioNTech says FDA lifts partial hold on its cancer drug trial
Aug 19, 2024
GDANSK, Aug 19 (Reuters) - BioNTech on Monday said the U.S. Food and Drug Administration (FDA) has lifted a partial clinical hold on an early stage study of its experimental cancer drug. The company has now included additional risk mitigation measures into investigator brochure and consent for patients, in line with the FDA's requirements, BioNTech said. The drug, an antibody-drug...
--New Oriental Education & Technology to Pay Special Cash Dividend of $0.06 to Shareholders of Record on Sept. 9
--New Oriental Education & Technology to Pay Special Cash Dividend of $0.06 to Shareholders of Record on Sept. 9
Aug 19, 2024
06:46 AM EDT, 08/19/2024 (MT Newswires) -- Price: 70.64, Change: -0.77, Percent Change: -1.08 ...
AstraZeneca, Daichi Sankyo get FDA Breakthrough Designation for Potential Breast Cancer Therapy
AstraZeneca, Daichi Sankyo get FDA Breakthrough Designation for Potential Breast Cancer Therapy
Aug 19, 2024
06:50 AM EDT, 08/19/2024 (MT Newswires) -- AstraZeneca ( AZN ) and Daiichi Sankyo said Monday that Enhertu has been granted US Food and Drug Administration Breakthrough Therapy Designation for the treatment of some breast cancer indications. The companies said the designation applies to the treatment of inoperable or metastatic hormone receptor-positive HER2 low or ultra-low breast cancer in patients...
AstraZeneca-Backed Breast Cancer Treatment Under European Regulatory Review for Type II Variation
AstraZeneca-Backed Breast Cancer Treatment Under European Regulatory Review for Type II Variation
Aug 19, 2024
06:55 AM EDT, 08/19/2024 (MT Newswires) -- Daiichi Sankyo said Monday that a Type II Variation application for its breast cancer therapy Enhertu, jointly developed with AstraZeneca ( AZN ) , is now up for review with the European Medicines Agency. The application adds an indication of Enhertu as treatment for an advanced breast cancer that can't be surgically removed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved